David Enloe is the CEO of Rose BioSolutions. Enloe is based in the United States.
Experienced biotech and pharmaceutical executive with over 35 years leading services businesses, including 30+ years in gene therapy and biopharmaceutical manufacturing. Previously founded Vivante GMP Solutions and served as CEO of Introgen Therapeutics and Societal CDMO.
Recent developments
AI summary of recent coverageRecent coverage has focused on David Enloe's appointment as Chief Executive Officer of Rose BioSolutions, a newly formed cell and gene therapy platform company. The coverage highlights Enloe's role in leading the scaling of the organization following GI Partners' acquisition of CDMO and cell solutions businesses that were combined to create Rose BioSolutions.
Summarized from the headlines below; see each source for the full story.
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on David Enloe, it will appear here — and tie into the news timeline.
David Enloe: FAQ
- Who is David Enloe?
- David Enloe is the Chief Executive Officer of Rose BioSolutions, based in United States.
- What company does David Enloe lead?
- David Enloe is CEO of Rose BioSolutions.